期刊文献+

凝血因子Ⅴ基因的一种新突变的发现与确证 被引量:5

A novel molecular mechanism of congenital FⅤ deficiency: mutation in the intron acceptor splice site of human blood coagulation FⅤ gene
原文传递
导出
摘要 目的 探讨先天性凝血因子Ⅴ (FⅤ )缺乏症的分子发病机制。方法 利用发色底物法检测血浆FⅤ凝血活性 ,采用PCR产物直接测序或T A克隆后测序、限制性酶切分析先证者FⅤ基因 ,并进行了一个家系和FⅤ基因多态性频率研究。结果 先证者 8号内含子 3′端剪接位点存在AG→GG的突变 ,这在家系和 10 0例正常对照人群的研究中得到证实。结论 FⅤ基因 8号内含子 3′端剪接位点的突变与先天性凝血因子Ⅴ缺乏症的发病有关。 Objective To explore the molecular mechanism involved in patient with congenital FⅤ deficiency. Methods Activity of FV was determined by biochemical method. The PCR products of FⅤ gene was analyzed by DNA sequencing directly or cloned into T vector prior to DNA analysis. The mutation of FⅤ gene in proband and his family numbers was analysed by restriction enzyme analysis. Its occurrence was investigated in the control group. DNA was extracted from the peripheral blood mono1nuclear cells of the proband, male, 18 years old, and his parents. The PCR products were analyzed by direct sequencing or cloned into T vector prior to DNA analysis. One hundred patients with different kind of hemotopathy were used as controls. Results A single point mutation, AG→GG was found at position 3′ splice site of intron 8 of the proband. This mutation was confirmed by family screening. Conclusion A single point mutation, AG→GG at position 3′ splice site of intron 8 mutation of FⅤ gene is related to the pathogenesis of congenital FV deficiency.
出处 《中华医学杂志》 CAS CSCD 北大核心 2003年第1期24-26,共3页 National Medical Journal of China
关键词 凝血因子V 凝固蛋白紊乱 基因突变 先天性凝血因子V缺乏症 发病机制 Factor Ⅴ Coagulation protein disorders Gene Mutation
  • 相关文献

参考文献15

  • 1Jenny RJ, Pittman DD, Toole JJ. et al. Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci U S A,1987,4:4846-4850.
  • 2傅卫军,侯健,王东星,章海燕,余润泉.一例凝血因子Ⅴ缺乏症患者成功施行颅内假性肿瘤清除术[J].中华血液学杂志,2002,23(3):150-150. 被引量:1
  • 3van Wijk R, Nieuwenhuis K, van den Berg M, et al. Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency. Blood,2001,98:358-367.
  • 4Guasch JF, Cannegieter S, Reitsma PH. et al. Severe coagulation factor V deficiency caused by a 4 bp deletion in the factor V gene. Br J Haematol,1998,101:32-39.
  • 5Guasch JF, Lensen RP, Bertina RM.Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance. Thromb Haemost,1997,77:252-257.
  • 6Murray JM, Rand MD, Egan JO. et al. Factor V New Brunswick: Ala221-to-Val substitution results in reduced cofactor activity.Blood,1995,86:1820-1827.
  • 7Castoldi E, Kalafatis M, Lunghi B. et al. Molecular bases of pseudo-homozygous APC resistance: the compound heterozygosity for FV R506Q and a FV null mutation results in the exclusive presence of FV Leiden molecules in plasma. Thromb Haemost,1998,80:403-406.
  • 8Mirochnik O, Halim-Kertanegara N, Henniker AJ, et al. A novel factor V null mutation at Arg 506 causes a false positive factor V Leiden result. Thromb Haemost,1999,82:1198-1199.
  • 9Zehnder JL, Hiraki DD, Jones CD, et al. Familial coagulation factor V deficiency caused by a novel 4 base pair insertion in the factor V gene: factor V Stanford. Thromb Haemost,1999,82:1097-1099.
  • 10Castoldi E, Simioni P, Kalafatis M, et al. Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family. Blood, 2000,96:1443-1448.

二级参考文献2

共引文献11

同被引文献41

  • 1丁红香,苏看看,胡立群,张海月,朱丽丹,杨丽红,金艳慧,王明山.一个遗传性FⅤ缺陷症家系的表型与基因变异分析[J].中华医学遗传学杂志,2019,36(11):1100-1103. 被引量:2
  • 2Van Wijk R, Nieuwenhuis K, Vanden M, et al. Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency. Blood, 2001, 98:358-367.
  • 3Chen TY, Lin TM, Chen HY,et al. Gly392Cys missense mutation in the A2 domain of factor V causing severe factor V deficiency:molecular characterization by expression of the recombinant protein. Thromb Haemost, 2005,93(3):614-615.
  • 4Seanavini D, Girelli D, Lunghi B,et al. Modulation of factor V levels in plasma by polymorphisms in the C2 domain. Arterioscler Thromb Vase Biol, 2004,24(1):200-206.
  • 5Soria JM, Blangero J, Souto JC, et al. Identification of a large deletion and three novel mutations in exon 13 of the factor V gene in a Spanish family with normal factor V coagulant and anticoagulant properties. Hum Genet, 2002,111:59-65.
  • 6Montefusco MC, Duga S, Asselta R, et al. A novel two base pair deletion in the factor V gene associated with severe factor V deficiency. Br J Haematol,2000,111:1240-1246.
  • 7Schrijver I, Hong DW, Mandle L, et al, High frequency of premature termination mutations in the factor V gene: three factor V deficiency case reports and a mutation review. Thromb Haemost,2005,g3(3) :610-611.
  • 8Schrijver I, Koerper MA, Jones CD, et al, Homozygous factor V splice site mutation associated with severe factor V deficiency.Blood, 2002,99 : 3063-3065.
  • 9Asselta R, Montefusco MC, Duga S , et al. Severe factor V deficiency: exon skipping in the factor V gene causing a partial deletion of the C1 domain. J Thromb Haemost, 2003,1:1237-1244.
  • 10Asselta R, Tenchini ML, Holme R, et al. The discovery of Mary's mutation. J Thromb Haemost,2003,1 : 397-398.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部